These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3509329)

  • 1. Studies on improvement of pharmaceutical preparations prescribed in hospitals. IV. Dibekacin sulfate viscous solution for treatment of mouth and throat wounds.
    Namiki N; Yokoyama H; Moriya K; Fukuda M; Takashima T; Uchida Y; Yuasa H; Kanaya Y
    Drug Des Deliv; 1986 Nov; 1(2):157-65. PubMed ID: 3509329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on improvement of pharmaceutical preparations prescribed in hospitals. II: Study on pharmaceutical manufacturing of dibekacin sulfate gauze tampon.
    Namiki N; Yokoyama H; Moriya K; Takashima T; Uchida Y; Yuasa H; Kanaya Y
    Drug Des Deliv; 1986 Aug; 1(1):71-81. PubMed ID: 3509322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Aerosol administration of dibekacin--the sputum concentration].
    Noguchi Y; Taguchi M; Takasugi M; Sakamoto T; Matsumoto K
    Jpn J Antibiot; 1983 Dec; 36(12):3405-11. PubMed ID: 6674552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical studies on dibekacin for infectious diseases following intramuscular and intravenous drip administration. Concentration in infected tissues and clinical responses (author's transl)].
    Nakamura T; Hashimoto I; Sawada Y; Mikami J; Bekki E; Kasai Y; Nakanishi M
    Jpn J Antibiot; 1981 Jun; 34(6):980-93. PubMed ID: 7289045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study on administration method of dibekacin].
    Soejima R; Tano Y; Niki Y; Katoh O
    Jpn J Antibiot; 1982 Dec; 35(12):2768-72. PubMed ID: 7182532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of an antibiotic coated indwelling catheter: a preliminary report.
    Sakamoto I; Umemura Y; Nakano H; Nihira H; Kitano T
    J Biomed Mater Res; 1985; 19(9):1031-41. PubMed ID: 3910651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fundamental and clinical studies on intravenous drip infusion of dibekacin in the pediatric field].
    Motohiro T; Tanaka K; Koga T; Shimada Y; Nishiyama T; Ishimoto K; Tominaga K; Yamashita F; Sakaguchi Y; Kimura K
    Jpn J Antibiot; 1985 Aug; 38(8):2068-86. PubMed ID: 4079001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies of dibekacin eye-drops. Intraocular penetration (author's transl)].
    Tomono N; Nakayoshi T; Fujita M; Kikai S; Oishi M
    Jpn J Antibiot; 1980 Jun; 33(6):685-9. PubMed ID: 7452907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical experience with dibekacin (DKB) intravenous drip in the field of thoracic surgery (author's transl)].
    Nakabayashi M; Yamazaki N; Ito T
    Jpn J Antibiot; 1978 Nov; 31(11):693-6. PubMed ID: 731868
    [No Abstract]   [Full Text] [Related]  

  • 10. [Fundamental studies of combination of antibiotics, especially on pharmacokinetics. III. Combination of ampicillin and dibekacin (author's transl)].
    Aratani H; Nakatsuka M
    Jpn J Antibiot; 1979 Jul; 32(7):711-9. PubMed ID: 490892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The intravenous toxicity of dibekacin sulphate (DKB) to female beagle dogs.
    James RW; Wadsworth PF; Chesterman H; Ball SA; Majeed SK; Heywood R; Street AE; Koeda T; Takeda U; Sasaki H
    Jpn J Antibiot; 1980 Aug; 33(8):749-57. PubMed ID: 7206221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dilute solution properties of carboxymethyl celluloses of various molecular weights and degrees of substitution.
    Arinaitwe E; Pawlik M
    Carbohydr Polym; 2014 Jan; 99():423-31. PubMed ID: 24274526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of protective effect of fosfomycin against aminoglycoside ototoxicity.
    Ohtani I; Ohtsuki K; Aikawa T; Sato Y; Anzai T; Ouchi J
    Auris Nasus Larynx; 1984; 11(3):119-24. PubMed ID: 6529372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Toxicological studies on dibekacin for intravenous injection use. II. Chronic toxicity in rats (author's transl)].
    Koeda T; Odaki M; Sasaki H; Yokota M; Niizato T; Watanabe H; Kawaoto H; Hirano F; Ishiwatari N; Watanuki T; Senoo A
    Jpn J Antibiot; 1980 May; 33(5):599-612. PubMed ID: 7431660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Plasma levels of dibekacin (DKB) following bronchial lavage using bronchofiberscope and nebulized aerosol administration via IPPB (author's transl)].
    Koga T; Shirakusa T; Shigematsu N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1979 May; 17(5):273-9. PubMed ID: 388010
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical studies of dibekacin intravenous challenge on respiratory tract infections (author's transl)].
    Hayashi I; Okamoto H
    Jpn J Antibiot; 1981 Jul; 34(7):1098-105. PubMed ID: 7321189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on the antigenicity of dibekacin (DKB), an aminoglycoside antibiotic, eye drops (author's transl)].
    Shiota H; Ohgushi J; Fujita Y
    Nippon Ganka Gakkai Zasshi; 1981 Sep; 85(9):1492-6. PubMed ID: 7325086
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dibekacin in the treatment of urinary infections in the elderly].
    Lopitaux R; Hermet R; Sirot J; Cluzel M
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):563-6. PubMed ID: 6462747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Combination action of sisomicin, dibekacin and cefotetan, cefotaxime, latamoxef, and cefsulodin against Escherichia coli, Serratia marcescens, and Pseudomonas aeruginosa].
    Saito M; Azuma K; Nishino T; Tanino T
    Jpn J Antibiot; 1983 Oct; 36(10):2833-43. PubMed ID: 6325746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation of Dibekacin in urinary tract infection in children.
    Tambunan T; Wila Wirya IG; Alatas H
    Paediatr Indones; 1982; 22(9-10):171-80. PubMed ID: 6763182
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.